| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |